Triple
Test
This is a screening test which is offered to
all pregnant women between 16 and 20 weeks of
pregnancy. A sample of blood is taken and the
levels of alphafetoprotein (AFP), and Estriol
(E3) Human Chorionic Gonadotrophin (HCG) are
measured. Hence the name triple test
and the results will normally be available in
10 days. |
Measurement of the levels of AFP determines
the risk of your baby having an abnormality such as
Spina Bifida.
Also by measuring the levels of AFP, Estriol and
HCG it is possible to estimate the risk of your baby
being born with a chromosomal abnormality such as
Down’s Syndrome.
Occasionally the test results are inconclusive, and
we may ask you to have the test repeated. Do not worry
about this since most tests would then fall within
the normal range.
It is important to remember that a screening test
only gives us an indication of the risks. The majority
of women will have perfectly normal results. If the
AFP/HCG/E3 levels are abnormal in any way, further
more decisive tests such as a detailed ultrasound
scan or amniocentesis may be suggested. If an abnormality
of any kind is found following these further tests
you may need to consider a termination of the pregnancy.
You might wish to discuss such possibilities with
your partner before deciding to have the antenatal
screening tests.
A Normal Result
Most pregnancies will have a normal test
result and a report will be conveyed
to you. If you have not heard from the doctor within
about 10 days you may assume the test is normal.
The test cannot identify every abnormality and a normal
AFP/HCG/E3 result is not a guarantee that your baby
will be healthy. However, if your test result is normal,
it will reduce the chance of an abnormality being
present.
A High Afp Result
This may indicate that the baby is at risk of having
a defect such as Spina Bifida.
If your result is high you will be advised to have
a detailed ultrasound scan. Following the scan
you will have the opportunity to discuss the significance
of the raised AFP and should any abnormality be found,
this would be fully discussed with you at the time.
About 9 out of 10 of Spina Bifida babies will be
detected by a raised AFP.
If the AFP level is raised and no abnormally has
been found, you will receive extra antenatal care,
because it has been shown that there may be a slightly
increased risk of these babies being smaller than
average.
The Afp/Hcg/E3 Result (Triple Test)
By measuring the AFP/HCG/E3 levels, and considering
your age and stage of pregnancy, it is possible to
estimate the risk of your baby being born with a chromosomal
abnormally such as Down’s Syndrome. Risk is
often quoted in terms such as 1 in 280 or 1:280. What
this means is that out of 280 pregnancies, then 1
of them will be affected and 279 will be normal.
If your risk is shown to be more than 1 in 400 of
having a baby affected by Down’s Syndrome
(for example 1 in 50), you will be set an appointment
to discuss this.
After discussion you may choose to have an amniocentesis
which will confirm whether or not the baby is affected.
Most women will have a normal amniocentesis result,
but if an abnormality of any kind is found it will
be fully explained to you and you will have ample
time to discuss this.
Overall, about 6 out of 140 Down’s Syndrome
babies will be detected by the Triple test. The rate
of detection has been shown to vary according to the
age of pregnant mother as shown. |